Sign in

CIK 0001395937

  • Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
320162505
Phone
+1 781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$113,716
in 1 filing, $114K under 10b5-1 plans

Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Podlesak Dennis −$114K Director sold 3% of stake

Reading 25 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-15 Ordentlich Peter Chief Scientific Officer Option exercise +7,572 $6.38 $48K 7,572
2023-02-15 Ordentlich Peter Chief Scientific Officer Sale −7,572 $25.84 $196K 0
2023-02-15 Ordentlich Peter Chief Scientific Officer Option exercise +17,428 $7.20 $125K 17,428
2023-02-15 Ordentlich Peter Chief Scientific Officer Sale −17,428 $25.84 $450K 0
2023-02-15 Ordentlich Peter Chief Scientific Officer Option exercise · Stock Options (Right to buy) −17,428 $25.84 $450K 0
2023-02-15 Ordentlich Peter Chief Scientific Officer Option exercise · Stock Options (Right to buy) −7,572 $25.84 $196K 0
2023-02-02 Ordentlich Peter Chief Scientific Officer Grant or award · Stock Options (Right to buy) +90,000 $28.55 $2.6M 90,000
2023-02-01 Ordentlich Peter Chief Scientific Officer Sale −69 $28.43 $2K 0
2023-01-31 Ordentlich Peter Chief Scientific Officer Other acquisition +69 $17.32 $1K 69
2022-12-02 Ordentlich Peter Chief Scientific Officer Option exercise +17,200 $6.38 $110K 17,465
2022-12-02 Ordentlich Peter Chief Scientific Officer Sale −17,200 $25.05 $431K 265
2022-12-02 Ordentlich Peter Chief Scientific Officer Option exercise · Stock Options (Right to buy) −17,200 0
2022-12-01 Ordentlich Peter Chief Scientific Officer Option exercise +3,772 $6.35 $24K 4,037
2022-12-01 Ordentlich Peter Chief Scientific Officer Sale −3,772 $25.01 $94K 265
2022-12-01 Ordentlich Peter Chief Scientific Officer Option exercise +4,028 $6.38 $26K 4,293
2022-12-01 Ordentlich Peter Chief Scientific Officer Sale −4,028 $25.01 $101K 265
2022-12-01 Ordentlich Peter Chief Scientific Officer Option exercise · Stock Options (Right to buy) −4,028 0
2022-12-01 Ordentlich Peter Chief Scientific Officer Option exercise · Stock Options (Right to buy) −3,772 0
2022-08-24 Ordentlich Peter Chief Scientific Officer Option exercise +22,846 $6.32 $144K 23,111
2022-08-24 Ordentlich Peter Chief Scientific Officer Sale −22,846 $25.04 $572K 265

Page 1 of 3 · 45 trades